Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Sandy Sargis
Advertisement
Sandy Sargis is a senior research associate in early-stage purification at Genentech, Inc.
Articles by Sandy Sargis
Advertisement
Latest Updated Articles
Advertisement
Advertisement